Abstract Gene transfer has been used to examine the role of putative neurotransmitters in the nucleus tractus solitarii (NTS). Most such studies used adenovirus vector-mediated gene transfer although adenovirus vector transfects both neuronal and non-neuronal cells. Successful transfection in the NTS has also been reported with lentivirus as the vector. Feline immunodeficiency virus (FIV), a lentivirus, may preferentially transfect neurons and could be a powerful tool to delineate physiological effects produced by altered synthesis of transmitters in neurons. However, it has not been studied in NTS. Therefore, we sought to determine whether FIV transfects rat NTS cells and to define the type of cell transfected. We found that injection of FIV encoding LacZ gene (FIVLacZ) into the NTS led to transfection of numerous NTS cells. Injection of FIVLacZ did not alter immunoreactivity (IR) for neuronal nitric oxide synthase, which we have shown resides in NTS neurons. A majority (91.7 ± 3.9%) of transfected cells contained IR for neuronal nuclear antigen, a neuronal marker; 2.1 ± 3.8% of transfected cells contained IR for glial fibrillary acidic protein, a glial marker. No transfected neurons or fibers were observed in the nodose ganglion, which sends afferents to the NTS. We conclude that FIV almost exclusively transfects neurons in the rat NTS from which it is not retrogradely transported. The cell-type specificity of FIV in the NTS may provide a molecular method to study local physiological functions mediated by potential neurotransmitters in the NTS.
Introduction
The nucleus tractus solitarii (NTS) plays an important role in central regulation of cardiovascular, digestive, gustatory, and respiratory functions (Kalia and Sullivan 1982; Kalia and Mesulam 1980) . Many potential neurotransmitters are present in the NTS, and some of them are implicated in modulating these functions (Lawrence and Jarrott 1996; Bradley et al. 1996) . Recently, gene transfer using replication-deficient recombinant viral vectors to up-or downregulate neurotransmitters has been used to examine the role of putative neurotransmitters in the NTS (Chen et al. 2006; Hirooka et al. 2003; Sakai et al. 2000) . For example, injection of adenovirus vector (Ad) encoding endothelial nitric oxide synthase (eNOS) into the NTS to increase production of nitric oxide (NO) decreased heart rate and blood pressure (Hirooka et al. 2003; Sakai et al. 2000) . Also, injection of Ad carrying the DNA sequence coding small hairpin RNA for angiotensin type 1 into the NTS caused a decrease in blood pressure with no effect on heart rate (Chen et al. 2006) . Another class of viral vector, lentivirus, appears to be a very promising tool for gene transfer into the brain. Lentiviruses have been shown to transduce signals effectively in NTS cells (Coleman et al. 2003) , and studies have shown that feline immunodeficiency virus (FIV), a type of lentivirus, may be an effective tool for transduction in gene therapy (Toupet et al. 2008) . Although both Ad and FIV have been considered promising vectors for gene transfer, they exhibit unique characteristics. While Ad transfects both neuronal and glial cells types (Davidson et al. 1993) , FIV has been found to preferentially transfect neurons in some areas of the brain (Alisky et al. 2003; Sinnayah et al. 2002) . What type of cell a vector transfects may be important in dissecting how a neurotransmitter system works when that vector is used to up-regulate or down-regulate a neurotransmitter in a specific area of the brain. FIV's capacity to transduce signals in neurons exclusively would be a powerful tool in delineating the role of certain neurotransmitters such as neuronal nitric oxide synthase (nNOS), which in the NTS is only found in neurons (Lin et al. 2007; Lin and Talman 2005) while endogenous eNOS is found in other cells in the same region (Lin et al. 2007 ). In the brain stem, lentivirus has been shown to preferentially transfect neurons in the hypoglossal and dorsal vagal motor nuclei (Duale et al. 2005) . The purpose of the current study was to test the hypothesis that FIV transduces signals in neurons in preference to glia in the rat NTS. We utilized immunofluorescent labels of neurons and glia to differentiate cell types and examined whether the expression of nNOS is altered after injection of FIV. Furthermore, we also studied if nNOS, which is expressed in NTS neurons (Lin et al. 2007; Lin and Talman 2005) , and not glia, is expressed in FIVtransfected NTS neurons. Finally, we examined the nodose ganglion (NG) for evidence of transfection after injection of FIV vector into the NTS in an effort to determine whether there is uptake and retrograde transport of the vector from NTS to the NG, the site of sensory afferent neurons that send arterial baroreceptor, chemoreceptor, and cardiopulmonary afferent axonal projections to the NTS (Dampney 1994).
Methods

Viral Vectors
A replication-deficient FIV vector encoding nucleartargeted LacZ gene (FIVLacZ) driven by cytomegalovirus (CMV) promotor was generated and titered by the University of Iowa the Gene Transfer Vector Core as described in detail previously (Brooks et al. 2002; Johnston et al. 1999) . The vector was generated by inserting CMVLacZ into the pVET L FIV backbone and produced through a triple transfection of a shuttle, a backbone, and an envelope vector (Brooks et al. 2002) . The titer of FIV vectors used in the current study was 4 9 10 9 pfu/ml.
Animals and Injections
All procedures conformed to standards established in the Guide for Care and Use of Laboratory Animals (National Academy Press, Washington, DC 1996). The Institutional Animal Care and Use Committees of the University of Iowa and Department of Veterans Affairs Medical Center, Iowa City reviewed and approved all protocols. Both institutions are AAALAC accredited. All efforts were made to minimize the number of animals used and to avoid their experiencing pain or distress. Adult male Sprague-Dawley rats (275-340 g) were anesthetized with halothane (5% induction followed by 1.5-2.0% maintenance) delivered in 100% O 2 (2 L/min) by a nasal mask. The dorsal surface of the brain stem was exposed, as previously described (Talman 1989) , and a glass micropipette filled with viral vectors was stereotactically placed (0.4 mm rostral to the calamus scriptorius, 0.5 mm from the midline, and 0.5 mm below the surface of the brain stem) unilaterally into the dorsolateral and medial subnuclear regions of the NTS at the level of the area postrema. Injections (individual increments of 25-50 nl to a combined total of 200 nl) were made over 15 min, and the pipette was left in place for 15 additional minutes to limit efflux of injectate from the pipette track. After recovery from anesthesia, the animal was returned to the animal care facility and then euthanized 1 (n = 2), 2 (n = 2), 4 (n = 3), and 15 (n = 3) days after the injection. Procedures for euthanasia and perfusion of the rats were the same as described in our earlier publications (Lin et al. 2007; Talman 2005, 2006 ). The brain stem was then removed, postfixed in 4% paraformaldehyde for 2 h and then cryoprotected for 2 days in 30% sucrose in phosphate buffered saline (PBS) at 4°C. Frozen 20-lm coronal sections were cut with a cryostat and processed for double-label immunofluorescent staining for b-galactosidase (bGal, the protein encoded by LacZ gene) and either glial marker glial fibrillary acidic protein (GFAP) or neuronal marker neuronal nuclear antigen (NeuN), or in some cases for bGal and nNOS. The ipsilateral nodose ganglion was removed after the rat was perfused as described earlier (Lin et al. 1998) . It was then postfixed for 1 h, transferred to 30% sucrose overnight, cut, mounted to slides, and processed for double-label immunofluorescent staining for bGal and protein gene product 9.5 (PGP 9.5), which is present in all neurons of the NG (unpublished observation). As a positive control for retrograde transport (Sinnayah et al. 2002; Vasquez et al. 2001) , adenovirus encoding LacZ gene (AdLacZ) of similar titer was injected unilaterally into the NTS of other rats (n = 3). The AdLacZ vectors were generated and titered by the University of Iowa Gene Transfer Vector Core. The AdLacZ injected rats were euthanized 15 days after the injection, and the NGs removed and processed as described previously for FIVLacZ injection.
Immunofluorescent Staining
Procedures similar to those in our previous publications (Lin et al. 2007; Talman 2005, 2006) were used for immunofluorescent staining. For double-label immunofluorescent staining for bGal and NeuN, brain stem sections were washed with PBS and then blocked with 10% donkey normal serum (Jackson ImmunoResearch Labs, USA) in PBS at 25°C for 1 h. Sections were then incubated in a mixture of rabbit anti-bGal antibody (1:200, Chemicon, USA) and mouse anti-NeuN (1:50, Chemicon) in 10% donkey normal serum for 24 h in a humid chamber at 25°C. The sensitivity and specificity of anti-bGal and antiNeuN antibodies have been shown and the antibodies used in many studies (McHugh et al. 2007; Lin et al. 2007; Iwata et al. 2004; Wells et al. 1998) . After being washed with PBS, sections were incubated with fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit IgG (1:200, Jackson ImmunoResearch Labs) and rhodamine red X (RRX)-conjugated donkey anti-mouse IgG (1:200, Jackson ImmunoResearch Labs) in PBS for 20-24 h at 4°C. Similar procedures were used for double-label immunofluorescent staining of bGal and GFAP, except that mouse anti-GFAP antibody (1:100, Sigma, USA) replaced NeuN antibody. The sensitivity and specificity of anti-GFAP antibody have been shown and the antibody used in many studies (Lin et al. 2007; Debus et al. 1983) . Procedures for double-label immunofluorescent staining of bGal and nNOS were similar to those described previously except that sheep anti-nNOS antibody (1:1000, K205, a generous gift from Dr. P. C. Emson) replaced NeuN antibody and RRX-conjugated anti-sheep IgG (1:200, Jackson ImmunoResearch Labs) replaced anti-mouse antibody. The sensitivity and specificity of K205 sheep anti-nNOS antibody have been reported, and the antibody has been used in a number of publications Lin et al. 2004; Simonian and Herbison 1996; Herbison et al. 1996) . Secondary antibodies for GFAP and nNOS were generated in donkey (Jackson ImmunoResearch Labs).
Stained sections were washed, air-dried, and mounted with Prolong Gold Antifade Reagents (Invitrogen-Molecular Probes, USA). Negative controls consisted of tissue processed (a) in the absence of primary antibodies or (b) after addition of only one of the primary antibodies. Similar procedures were used for double-label immunofluorescent staining of bGal and PGP9.5 of NG except that Guinea pig anti-PGP9.5 (1:100, Chemicon) replaced NeuN antibody, and RRX-conjugated donkey anti-Guinea pig IgG (1:200, ImmunoResearch Labs) replaced anti-mouse antibody. Stained NTS sections and NG sections were examined with a Zeiss confocal microscope as described in the following section.
Confocal Laser Scanning Microscopy
Procedures similar to those in our previous publications were used (Lin et al. 2007; Lin and Talman 2006) . Labeled sections were analyzed with a Zeiss LSM 510 confocal laser scanning microscope. In brief, we scanned specimens sequentially by two channels to separate labels. For optimal visualization of the relationship between RRX-and FITClabeled elements, images from two channels were assigned the pseudocolor red (for RRX) and green (for FITC), and then were superimposed. Confocal images were obtained and processed with software provided with the Zeiss LSM 510. Adobe Photoshop image editing software (Adobe Photoshop CS2) was used to examine whether a structure had single labeling or double labeling by switching between channels on the monitor. Another image editing program, Microsoft PowerPoint (2003), was used to create montages. Contrast and brightness of images were the only variables we adjusted digitally.
Cell Counts
We counted stained cells in images of 3-4 selected sections from each rat. We avoided analysis of sequential sections so that sections used for counting were at least 20 lm (the thickness of the sections) apart. Therefore, we minimized the possibility that the same stained neurons would be counted twice. Stained cells in each section were counted three times, first using the green channel for the number of bGal positive cells, then the red channel for NeuN or GFAP positive neurons, and finally the combined channel for double-stained neurons. The percentage of single-to double-labeled cells in each section was calculated after each section had been counted. Percentages of single-to double-labeled cells in NTS subnuclei were expressed as mean ± SD.
Results
FIVLacZ in NTS
In control experiments, no fluorescent staining of either RRX or FITC was apparent when the respective primary antibody had been omitted (figure not shown). Confocal analysis of immunofluorescent staining for bGal revealed localized and site-specific transfection in the NTS after FIVLacZ (Fig. 1b) had been microinjected to the NTS. FIVLacZ-transfected cells, exhibiting bGal-immunoreactivity (IR), in the NTS appeared to be distributed evenly in the NTS. In contrast, the contralateral side of the NTS showed very few cells that were positive for bGal-IR. The number of transfected cells in the NTS increased from the first through the fifteenth day after injection. We observed 13 ± 3 cells per section in the injected NTS (at the site of injection) at 1 day after the injection, 37 ± 4 cells at 2 days, 233 ± 26 cells at 4 days, and 346 ± 38 cells at 15 days after the injection.
FIVLacZ Expressing Cell Types in NTS
Double-label immunofluorescent staining showed that NTS cells were positive for bGal-IR after FIVLacZ injection, and often they were also positive for NeuN-IR (Fig. 2a-c) but negative for GFAP-IR (Fig. 2d-f) . Of the NTS cells that were positive for bGal-IR, 91.7 ± 3.9% also contained NeuN-IR while only 2.1 ± 3.8% also contained GFAP-IR. This analysis did not include rats that were euthanized 1 and 2 days after the injection because of the limited number of transfected cells seen at those two times. However, as was found at 4 and 15 days, the majority of transfected cells in the NTS of rats euthanized 1 and 2 days after the injection of FIVLacZ were positive for NeuN-IR.
FIVLacZ and nNOS in NTS
We observed that the staining pattern and intensity of nNOS-IR in the injected side of the NTS was not different from that of the contralateral side after the injection of FIVLacZ (Fig. 1e, f) at any of the time points. In addition, when confocal images for bGal-IR and nNOS-IR were merged, we noted that some NTS cells that were positive for bGal-IR were also positive for nNOS-IR (Fig. 2g, h ).
For example, in the medial subnucleus 22.1 ± 7.1% bGal-IR cells were nNOS-IR positive. NTS cells that were labeled for bGal-IR alone and nNOS-IR alone were also observed.
FIVLacZ and AdLacZ in NG
We did not observe any cells or fibers positive for bGal-IR in the NG at any time point after FIVLacZ had been injected into the NTS (Fig. 3a) . In contrast, consistent with findings in other areas of the brain (Sinnayah et al. 2002; Vasquez et al. 2001 ), many cells and fibers stained for bGal were observed in the ipsilateral NG (Fig. 3a) after injection of AdLacZ into the NTS (Fig. 3b) . Most of these bGal-IR positive cells and fibers were also labeled for PGP9.5-IR (Fig. 3d) 
Discussion
Our study demonstrates that FIV vectors transfect signals in NTS cells and that the majority of transfected NTS cells are neurons as indicated by their expressing NeuN-IR. In addition, our study shows that FIV vectors are not retrogradely transported from NTS to NG neurons.
Our finding that FIV vectors preferentially transfect neurons in the NTS is consistent with results of earlier studies with FIV or other lentiviral vectors in the hypoglossal and dorsal vagal motor nuclei in the brain stem (Duale et al. 2005) and in other brain areas (Sinnayah et al. 2002; Naldini et al. 1996) . The reason that FIV demonstrates such tropism is not well understood; however, some conjecture that the presence of receptors for the virus in neurons may play a role (Vigna and Naldini 2000) . Though the mechanism of its cytoselectivity remains to be elucidated, this selectivity makes FIV, in contrast to Ad, which transfects mainly glia (Allen et al. 2006 ), a suitable virus for gene transfection in NTS neurons. That property of the virus would likely yield more interpretable results when studies are aimed at peptides that typically reside in neurons. For example, when seeking to study the role of nNOS within the NTS where the enzyme is found exclusively in neurons (Lin et al. 2007; Lin and Talman 2005) , FIV would target the site of the endogenous enzyme.
After FIV was injected into the NTS, we did not see signs of FIV transfection in the NG; therefore, we found no evidence that it underwent retrograde transport from the NTS. The observation that FIV is not transported in axons is consistent with reports in other brain areas (Alisky et al. 2003; Sinnayah et al. 2002) . The restricted transfection of FIV to the site of injection may be useful when gene transfer confined to a well-defined area is desired. On the other hand, after AdLacZ was injected into the NTS, we observed its expression in NG neurons and fibers. This property of Ad, uptake by nerve terminals at the primary injection site and retrograde transport to afferent neurons, has been shown in other reports (Sinnayah et al. 2002; Vasquez et al. 2001) . Therefore, Ad may be a vector of choice when seeking to deliver gene to specific neurons that are not easily approachable. For example, a subgroup of neurons in the subfornical organ can be targeted by retrograde transport of AdLacZ from the supraoptic nucleus (Sinnayah et al. 2002) . In the NTS, Ad may be useful as a retrograde tracer, by itself or combined with other methods, to study areas that project to this nucleus; but, as others have emphasized, with cautious interpretation of results given the local effects of that vector on glia at its site of introduction (Allen et al. 2006) . In contrast to Ad, FIV would be the vector of choice when targeting neurons at the site where the vector had been introduced. In the latter case, resulting physiological changes could be more reliably attributed to effects on those local neurons.
There are other unique properties of FIV as a vector in transgene expression of non-dividing cells. One such characteristic is that transgene expression using FIV vector lasts for a longer period of time. Our preliminary data (not shown) indicated that expression of FIV lasted for at least 5 weeks, and one published study has demonstrated that transfection with lentivirus lasts for at least 3 months (Naldini et al. 1996) . In addition, FIV vectors do not produce cytotoxicity and inflammation, which are common with the Ad vector (Witlox et al. 2007; Lowenstein and Castro 2003; Amalfitano and Parks 2002) . Furthermore, our data suggest that transfection through use of FIV does not alter the expression of neuronal enzymes that have not been targeted by the vector. Specifically, we show that neurons that were transfected by FIVLacZ were able to express nNOS. Thus, it appears that FIV vector can be used as a powerful gene-transfer tool to target specific modulating systems, such as the nitroxidergic and glutamatergic system Talman 1997) , that are implicated in NTS control of physiological functions (Lawrence and Jarrott 1996) . 
